Crossmark Global Holdings Inc. Sells 9,693 Shares of DocuSign, Inc. (NASDAQ:DOCU)

Crossmark Global Holdings Inc. trimmed its position in DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 46.9% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 10,996 shares of the company's stock after selling 9,693 shares during the period. Crossmark Global Holdings Inc.'s holdings in DocuSign were worth $989,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Toronto Dominion Bank boosted its stake in DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company's stock valued at $1,624,000 after acquiring an additional 6,081 shares during the last quarter. Inspire Investing LLC bought a new position in DocuSign during the third quarter worth about $911,000. Charles Schwab Investment Management Inc. increased its stake in shares of DocuSign by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company's stock worth $82,478,000 after purchasing an additional 16,014 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of DocuSign by 5,660.8% in the third quarter. International Assets Investment Management LLC now owns 438,914 shares of the company's stock valued at $27,252,000 after purchasing an additional 431,295 shares during the period. Finally, Quantinno Capital Management LP lifted its stake in shares of DocuSign by 39.5% during the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company's stock valued at $12,514,000 after buying an additional 57,104 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. JMP Securities reiterated a "market outperform" rating and issued a $124.00 price target on shares of DocuSign in a research report on Tuesday, January 7th. HSBC reaffirmed a "reduce" rating on shares of DocuSign in a research note on Friday, December 6th. JPMorgan Chase & Co. boosted their target price on DocuSign from $50.00 to $70.00 and gave the stock an "underweight" rating in a research report on Tuesday, December 3rd. Piper Sandler raised their price target on DocuSign from $60.00 to $90.00 and gave the company a "neutral" rating in a report on Friday, December 6th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $90.00 target price (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $92.45.

Insiders Place Their Bets

In other DocuSign news, CEO Allan C. Thygesen sold 7,763 shares of the company's stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $80.54, for a total value of $625,232.02. Following the sale, the chief executive officer now owns 100,062 shares in the company, valued at approximately $8,058,993.48. This represents a 7.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the transaction, the director now directly owns 7,736 shares of the company's stock, valued at approximately $731,825.60. This trade represents a 6.46 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 693,537 shares of company stock valued at $66,575,817 over the last three months. Insiders own 1.66% of the company's stock.

DocuSign Trading Up 1.2 %

Shares of DOCU traded up $1.06 during mid-day trading on Friday, reaching $91.60. The company's stock had a trading volume of 2,251,473 shares, compared to its average volume of 1,725,834. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company's fifty day moving average price is $89.76 and its two-hundred day moving average price is $71.43. The stock has a market cap of $18.51 billion, a PE ratio of 18.89, a P/E/G ratio of 8.30 and a beta of 0.88.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.